Effect of Imidazoline Drugs on Human Blood Platelet Aggregation

Summary

The effect of seven commonly used in therapy imidazoline derivatives on human blood platelet aggregation was studied. Three of the agents, i.e. clonidine, antazoline and tetryzoline were classified as partial agonists of the receptor responsible for aggregation. Two other drugs, i.e. phentolamine and tolazoline act as competitive antagonists of relatively high receptor affinity. The remaining imidazolines: xylometazoline and naphazoline effectively inhibit the platelet receptor in a non-competitive manner. The last two compounds seem to be selective alpha2-adrenoceptor antagonists.

Key words

Platelet aggregation - Imidazoline drugs - effect on - Alpha₂-adrenoceptors

• References

• 1 Van Rossum JM. Cumulative dose-response curves. Arch int Phar-macodyn 1963; 143: 299-330
• 2 Langer SZ. Presynaptic regulation of catecholamine release. Biochem Pharmacol 1974; 23: 1793-1800
• 3 Starke K, Endo T, Taube HD. Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmidebergs Arch Pharmacol 1975; 291: 55-78
• 4 Langer SZ. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 1977; 60: 481-497
• 5 Langer SZ. Presynaptic regulation of the release of catecholamines. Pharmacol Rev 1981; 32: 337-362
• 6 Starke K. Regulation of noradrenaline release by presynaptic receptor system. Rev Physiol Biochem Pharmacol 1977; 77: 1-124
• 7 Starke K. Alpha-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 1981; 88: 199-236
• 8 Cavero J, Gomeni R, Lefevre-Borg F, Roach AG. Comparison of mianserine and desipramine, maprotiline and phentolamine on cardiac presynaptic and vascular postsynaptic alpha-adrenoreceptors and noradrenaline reuptake in pithed normotensive rats. Br J Pharmacol 1980; 68: 321-329
• 9 Weitzell R, Tanaka T, Starke K. Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmitters in the pulmonary artery of the rabbit. Naunyn Schmidebergs Arch Pharmacol 1979; 308: 127-136
• 10 Hoffman BB, De Lean A, Wood CL, Schocken DD, Lefkowitz RJ. Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. Life Sci 1979; 24: 1739-1746
• 11 Sabol SS, Nirenberg M. Norepinephrine inhibit adenylate cyclase of neuroblastoma glioma hybrid cells via alpha-adrenergic receptors and converts cells to a norepinephrine dependent state. Fed Proc 1977; 36: 736-742
• 12 Pettinger WA. Unusual alpha-adrenergic receptor potency of methyl-dopa metabolites on melanocyte function. J Pharmacol Exp Ther 1977; 210: 622-626
• 13 Timmermans PB M W M, Van Zwieten PA. Alpha2-adrenoceptors: Classification, localization, mechanisms, and targets for drugs. J Med Chem 1982; 25: 1389-1401
• 14 Grant JA, Scrutton MC. Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br J Pharmacol 1980; 71: 121-134
• 15 O’Brien JR. Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo. Nature Lond 1963; 200: 763-764
• 16 Mills DC B, Roberts GC K. Effects of adrenaline on human blood platelets. J Physiol Lond 1967; 193: 443-453
• 17 Bydgeman S, Johnson O. Studies on the effect of adrenergic blocking drugs on catecholamine-induced platelet aggregation and uptake of noradrenaline and 5-hydroxytryptamine. Acta Physiol Scand 1969; 75: 129-139
• 18 Bom GV R, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178-195
• 19 Waud DR. On the measurement of the affinity of partial agonists for receptors. J Pharmacol Exp Therap 1969; 170: 117-122
• 20 Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol 1959; 14: 48-58